IN8bio Stock Quote INAB - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
IN8bio Inc (INAB) Quote

IN8bio Inc (INAB)

0.3055

-0.011

(-3.48%)

Closed September 17 4:00PM

Delayed by 15 minutes

0.3055

0.00

(0.00%)

After Hours: 6:55PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.3055

Bid

0.31

Ask

0.3195

Volume

122,259

0.30 Day's Range 0.32

0.2811 52 Week Range 2.48

Market Cap

Previous Close

0.3165

Open

0.32

Last Trade

Last Trade Time

Financial Volume

$ 38,063

VWAP

0.31133

Average Volume (3m)

245,781

Shares Outstanding

46,786,948

Dividend Yield

-

PE Ratio

-0.48

Earnings Per Share (EPS)

-0.64

Revenue

-

Net Profit

-30.01M

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.in8bio.com

Headquarters

Wilmington, Delaware, USA

Founded

-

IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $0.32. Over the last year, IN8bio shares have traded in a share price range of $ 0.2811 to $ 2.48.

IN8bio currently has 46,786,948 shares outstanding. The market capitalization of IN8bio is $14.81 million. IN8bio has a price to earnings ratio (PE ratio) of -0.48.

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia

Top Priority Clinical Program: Working to drive significant value creation with INB-100 for AML; ongoing trial is actively enrolling additional patients into the expansion cohort to further...

IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NEW YORK, Aug. 29, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0051	1.69773635153	0.3004	0.33	0.2811	182470	0.30468133	CS
4	-0.3855	-55.7887120116	0.691	0.691	0.2811	411781	0.41096917	CS
12	-0.5605	-64.7228637413	0.866	0.9489	0.2811	245781	0.57093428	CS
26	-0.9345	-75.3629032258	1.24	1.74	0.2811	393132	0.99658074	CS
52	-0.6145	-66.7934782609	0.92	2.48	0.2811	390098	1.22695343	CS
156	-7.9245	-96.2879708384	8.23	9.4241	0.2811	588167	2.37104382	CS
260	-9.6945	-96.945	10	10.319	0.2811	567004	2.41473835	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NCNANuCana PLC	$ 6.28 (147.24%)	66.83M
BBLGBone Biologics Corporation	$ 1.87 (133.75%)	161.15M
REEREE Automotive Ltd	$ 4.365 (47.22%)	12.39M
DRMADermata Therapeutics Inc	$ 2.26 (43.04%)	24.23M
IMRXImmuneering Corporation	$ 2.86 (41.58%)	65.96M
JBDIJBDI Holdings Ltd	$ 2.18 (-91.76%)	19.82M
TOIIWOncology Institute Inc	$ 0.0106 (-43.92%)	1.07k
LDTCLeddarTech Holdings Inc	$ 0.3105 (-29.70%)	1.08M
HPHHighest Performances Holdings Inc	$ 0.601 (-29.29%)	465.7k
ITOSiTeos Therapeutics Inc	$ 12.08 (-27.66%)	5.57M
NVDANVIDIA Corporation	$ 116.78 (-1.95%)	248.77M
MLGOMicroAlgo Inc	$ 0.2708 (16.98%)	205.51M
BBLGBone Biologics Corporation	$ 1.87 (133.75%)	161.15M
INTCIntel Corporation	$ 20.91 (6.36%)	149.28M
SQQQProShares UltraPro Short QQQ	$ 8.30 (1.59%)	119.21M

BurgerKing82

BurgerKing82 2 weeks ago

glenn1919

glenn1919 2 weeks ago

INAB...........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

TheFinalCD

TheFinalCD 2 weeks ago

$INAB 49% workforce reduction, focusing on INB-100https://t.co/C30I7yWH1v— Michelle Solly (@MSollender) September 4, 2024

Monksdream

Monksdream 1 month ago

INAB new 52 week low

glenn1919

glenn1919 3 months ago

INAB....................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 4 months ago

INAB.................................https://stockcharts.com/h-sc/ui?s=INAB
&p=W&b=5&g=0&id=p86431144783

Tyrus603

Tyrus603 5 months ago

Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.

Laster

Laster 5 months ago

Sold my shares this morning that I bought last night for small loss.
Volume not great. No PM movement (yet).
Who knows. It may surprise and take off at 9:30 open.
If it does, then congrats to y’all.

Invest-in-America

Invest-in-America 5 months ago

INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

BOTTOM LINE??? GO-GO-GO-INAB!!!!

glenn1919

glenn1919 6 months ago

INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 7 months ago

murocman

murocman 9 months ago

Surprised how much this has tanked in light of stellar data?

Murocman

murocman

murocman 9 months ago

Outstanding data and financing in place to boot!

Should move up!

Murocman

Awl416

Awl416 9 months ago

IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia

Monksdream

Monksdream 12 months ago

Monksdream

Monksdream 1 year ago

INAB new 52 week low

Monksdream

Monksdream 1 year ago

INAB new 52 week low

The Night Stalker

The Night Stalker 1 year ago

https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

Mr Wick

Mr Wick 1 year ago

New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
Fingers crossed.

The Night Stalker

The Night Stalker 1 year ago

MrMocha

MrMocha 1 year ago

I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!

Mr Wick

Mr Wick 1 year ago

New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
Looking forward to a buyout.

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

Trons

Trons 1 year ago

Headed to $20 on cancer developments

Jess070283

Jess070283 1 year ago

Uh oh Shorts I’m trouble….

trendzone

trendzone 1 year ago

Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.

Jess070283

Jess070283 1 year ago

Loading this dip for the rip…

Invest-in-America

Invest-in-America 1 year ago

INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)

TheFinalCD

TheFinalCD 1 year ago

Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target

subslover

subslover 1 year ago

Love your scanner! :)

2020Benzo

2020Benzo 1 year ago

Did they just post same Orphan Drug news twice in a row it’s sane PR !

TheFinalCD

TheFinalCD 1 year ago

surf1944

surf1944 1 year ago

https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/inab/opinion

Back down to $1

ringo1

ringo1 1 year ago

Time to take some profits

Hercules1

Hercules1 1 year ago

It hit $3.95.

$4 break is coming.

$5 quite possible today.

Hercules1

Hercules1 1 year ago

Total beast.

Next stop $4.

And then $5.

Awl416

Awl416 1 year ago

Jess070283

Jess070283 1 year ago

Invest-in-America

Invest-in-America 1 year ago

INAB: Maybe I've gone BONKERS, but this little freak show could hit TEN-BUCKS-A-SHARE today, Peeps!!!! (At least that's what my 'SCANNER' just told me!! See below!!)

Hercules1

Hercules1 1 year ago

This skyrockets to $5 today.

This is just getting started.

Skillful Craftsman Educa...

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions